Physician profile
Assaf Tzur
NPI 1295889848
$8,197.80
in general payments reported to CMS, 2019-2025
19 companies · $3,415 in 2025
The $3,415 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $1,009 · 2021: $397 · 2022: $748 · 2023: $495 · 2024: $1,552 · 2025: $3,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,986 · Travel and Lodging: $2,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,986.48 |
| Travel and Lodging | $2,475.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,522.25 | 2019-2025 | General - Therapies, Lux-Dx Insertable Cardiac Monitor, General - Tachy |
| Medtronic, INC. | $1,153.98 | 2021-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan |
| Medical Device Business Services, INC. | $971.37 | 2019-2020 | |
| Abbott Laboratories | $289.38 | 2019-2025 | Ensite, Aveir, Jot Dx |
| Biosense Webster, INC. | $235.87 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.43 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $149.69 | 2019-2022 | |
| Pfizer INC. | $137.89 | 2019-2024 | |
| Angiodynamics, INC. | $137.46 | 2019-2020 | |
| Philips North America LLC | $66.67 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Astrazeneca Pharmaceuticals LP | $65.60 | 2024-2025 | Farxiga |
| Biotronik INC. | $50.73 | 2021 | |
| Davol INC. | $48.82 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.95 | 2020-2024 | Jardiance |
| Stryker Corporation | $34.52 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $19.04 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.65 | 2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $15.69 | 2023 | |
| Medtronic Vascular, INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Assaf Tzur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.